News Bundle: 41 Hot Biotech Stocks to Watch Posted

New Post Public Reply Private Reply Replies (1) Message Board
fitzkarz iftheresaway #19386

News Bundle: 41 Hot Biotech Stocks to Watch

Posted by on Jan 22, 2013

Biotech stocks failed to join a broad market rally on Friday with Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) losing the most after a Seeking Alpha article claimed a competing debate over whether hedge funds are bullish or bearish on the equity.

Zalicus Inc (NASDAQ:ZLCS) tumbled 5.9% on a sale of 113000 shares by the company’s CEO.
Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) lost 5.26%, facing a weekly fall of 6.09% to trim year-to-date rally to 2.86%.

Celsion Corporation (NASDAQ:CLSN) plunged 4.24%, extending decline after analysts at Brean Capital downgraded the stock to a “sell” from a “buy” rating.

Biosante Pharmaceuticals Inc (NASDAQ:BPAX) fell 3.08% while ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Sequenom, Inc. (NASDAQ:SQNM), Theravance Inc (NASDAQ:THRX) and Dendreon Corporation (NASDAQ NDN) each decreased less than 3%.

VIVUS, Inc. (NASDAQ:VVUS) extended fall a day after Brean Capital downgraded the VVUS stock to “Sell” from “Hold”.

Amgen, Inc. (NASDAQ:AMGN) was down on Friday. The world’s largest biotechnology firm has recently marked a key lobbying victory in the recent fiscal-cliff deal as has a section granting the company an additional two years to sell Sensipar without government controls.

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) declined about 1.5%, suffering third fall in a row after the company declared an underwritten public offering of 4,400,000 shares of its common stock.
Illumina, Inc. (NASDAQ:ILMN) edged down after San Diego-based company was seen as attractive takeover target.

InterMune, Inc. (NASDAQ:ITMN) dropped 0.50% after it priced Public Offerings.
NuPathe Inc (NASDAQ ATH) traded actively on Friday but was unable to extend rally it saw on Thursday after the U.S. Food and Drug Administration (FDA) approved Zecuity for the acute treatment of migraine.

More on the down side, MannKind Corporation (NASDAQ:MNKD), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Hemispherx BioPharma, Inc (NYSEAMEX:HEB), Peregrine Pharmaceuticals (NASDAQ PHM), Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) and PDL BioPharma Inc. (NASDAQ DLI) all ended in negative territory.

Despite hitting new high, YM BioSciences Inc. (USA) (NYSEAMEX:YMI) made no change by the of close on Friday.

Surprisingly there were 5 more stocks in the biotechnology industry including Inovio Pharmaceuticals, Inc. (NYSEAMEX:INO), Exelixis, Inc. (NASDAQ:EXEL), Galena Biopharma Inc (NASDAQ:GALE), Geron Corporation (NASDAQ:GERN) and Cell Therapeutics Inc (NASDAQ:CTIC) that ended the day at breakeven level.

On the positive side, Viropharma Inc (NASDAQ:VPHM) was among top gainers after a report that key product Cinryze (C1 esterase inhibitor [human]) was found useful in providing relief from the symptoms of hereditary angioedema (HAE) attacks in pediatric patients and also helped decrease the rate of attacks.
Medivation, Inc. (NASDAQ:MDVN) jumped 2.75%, trimming early decline to end the day at $54.94. On Monday, analysts at Zacks upgraded the MDVN stock from a “neutral” rating to an “outperform” rating.

Celgene Corporation (NASDAQ:CELG) hit all-time high after Forbes reported that Wall Street is optimistic about the company, which is scheduled to release its fourth quarter earnings on Thursday, January 24, 2013.

ImmunoGen, Inc. (NASDAQ:IMGN) rallied after the company unveiled a plan to host a conference call at 8:00 a.m. ET on Friday, January 25, 2013, to discuss its corporate results for the three-month period ended December 31, 2012, the second quarter of the Company’s 2013 fiscal year.
CEL-SCI Corporation (NYSEAMEX:CVM) successfully rebounded from a decline near record low while Seattle Genetics, Inc. (NASDAQ:SGEN) and Gilead Sciences, Inc. (NASDAQ:GILD) traded near 52-week high.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) marked its best since IPO after the company reported inducement grants under NASDAQ Listing Rule 5635(c)(4).

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) ended in green after a plan to present a corporate update at the upcoming Noble Financial Capital Markets’ Ninth Annual Equity Conference on Wednesday, January 23, 2013 at 9:30 a.m. EST to be held at the Hard Rock Hotel in Hollywood, FL.

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) and Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) both recorded gains of more than 1.2% while Nektar Therapeutics (NASDAQ:NKTR), Biogen Idec Inc. (NASDAQ:BIIB) and Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) each added less than 1% in price.

I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Brands Must Choose: Cost or Value Leadership?

Updated Category News Views 6

Navigating the Business Jungle: Strategic Choices Unveiled If you've ever found yourself tangled in a web of corporate doublespeak, then you'll nod along with this: all those lofty brand management strategies often boil down to a fight over dollars or dizzying customer satisfaction. What's the winning play? According to Info-Tech Research Group, it's about firmly standing...

Continue Reading
Starr Conspiracy Unveils AI Tool for B2B Tech Firms

Updated Category News Views 5

AI-Driven Insight in Minutes: A Game Changer for B2B Hold onto your hats, because The Starr Conspiracy just lit a fire in the B2B tech world with its latest offering—Battle Card Builder. This free tool cranks out competitive intelligence in no time, literally about four minutes. Geared specifically for B2B tech marketing and sales teams, it combines decades of know-how...

Continue Reading
NSF Backs New Space Projects: Cooling & Drug Delivery

Updated Category News Views 7

You know, every time we think we're at the edge of current science, space reminds us how little we actually know. From the International Space Station up there in low Earth orbit, fresh experiments are kicking off to change what we understand about electronics cooling and drug delivery. It's a classic scenario of reaching for the stars to help us out back here on Earth....

Continue Reading
New Podcast by Paralyzed Veterans of America Offers Unique Insights

Updated Category News Views 6

Empowering Veterans Through Storytelling Some stories don't just rattle around in your headphones—they stick with you. The 'Voices of PVA' podcast, launched by Paralyzed Veterans of America, aims to do exactly that. It's not just a podcast; it's a platform where voices of veterans and people with spinal cord injuries like MS and ALS aren't just heard, they're amplified....

Continue Reading
Microplastics Webinar: Navigating Complex Regulations

Updated Category News Views 7

Buckle up, folks. The plastics debate is where regulatory battles and environmental concerns collide, and big changes are on the horizon. Let's talk about Bergeson & Campbell's latest shindig: "Plastics and Policy: Microplastics, EPR, and Other Emerging Trends"—a free-to-join webinar aiming to lift the lid on what's brewing beneath the surface of regulatory waters. The...

Continue Reading
Unicycive's Legal Turmoil: Opportunity for Investor Action

Updated Category News Views 5

Unicycive's Legal Headache: What's Brewing? Here we go again, folks. If you're holding shares of Unicycive Therapeutics, Inc. (UNCY), buckle up because it's looking like a storm's on the horizon. The Law Offices of Howard G. Smith have dropped the news that shareholders can step up to lead a securities fraud class action lawsuit against the company. That chance to be part...

Continue Reading
Lincoln Educational Services Faces Securities Fraud Suit

Updated Category News Views 4

A Storm Brews Over Lincoln Educational Services You know, there's nothing quite like the stink of a good mess in the markets, and Lincoln Educational Services Corporation has found itself knee-deep in one. The buzz is all about some securities fraud allegations that could rope in a bunch of investors who got the short end of the stick. It’s lawsuits like these that make...

Continue Reading
Subaru, Motorq Offer Hardware-Free Fleet Telematics Insights

Updated Category News Views 5

An Unplugged Move in Fleet Management There's something brewing between Motorq and Subaru that could shake up fleet operations in ways most haven't thought possible yet. We’re talking about cutting those pesky hardware cords and diving straight into a future that's software-driven—and hey, we're all here for it. Direct, Data-Driven Leadership Imagine you're a fleet...

Continue Reading
CATL Opens Europe's Largest Battery Service Hub

Updated Category News Views 6

A New Era for EV Batteries in Norway Stepping into Oslo's tech realm, CATL's grand opening is not just another corporate ribbon-cutting spree. It's a big splash in Europe's battery pool, boasting the largest NING SERVICE center outside of Asia. Here we are, folks, at the crossroads where the EV market meets the nitty-gritty of practical service. Norway's Electric...

Continue Reading
NORD Honors Innovators Shaping Rare Disease Treatment

Updated Category News Views 9

Saluting the Trailblazers in Rare Disease Space Alright, let's cut to it. In a world flooded with more rare diseases than most of us can count, about 10,000 of them, only a measly 5% have any kind of approved treatment. The National Organization for Rare Disorders (NORD) is out here celebrating the folks who dare to change that bleak outlook. With the 2026 Rare Impact...

Continue Reading

Top 5 Most Recently Viewed Articles

Locafy Expands Horizons with Localizer in Insurance Market

Updated Category News Views 122

Locafy’s Localizer Product Gains Traction in the Insurance Sector Locafy Limited, a pioneering software-as-a-service company, is witnessing a remarkable surge in sales due to the rapid adoption of its Localizer product. This innovative solution is specifically designed to help businesses secure prominent positions in local search results, a necessity in today’s...

Continue Reading
Super Micro Computer's Recent Stock Split Explained

Updated Category News Views 179

Super Micro Computer (NASDAQ: SMCI) took a bold step in its trading saga back in 2024 with a significant stock split that’s got traders buzzing. This event aimed to bring their share price down to earth—dropping from around $400 to approximately $40—with the expectation that it would make shares more accessible as they ride the artificial intelligence (AI) wave. The...

Continue Reading
Generative AI Solutions Corp. Welcomes New CEO Patrick Gray

Updated Category News Views 437

Generative AI Solutions Corp. Promotes Patrick Gray to CEO Generative AI Solutions Corp. has made a significant leadership change by naming Patrick Gray as the Chief Executive Officer of the company. This transition marks an exciting new chapter for the organization as they prepare to accelerate growth in the rapidly evolving field of artificial intelligence. Leadership...

Continue Reading
American Cancer Society's $43 Million Investment in Innovation

Updated Category News Views 310

Innovative Investments by BrightEdge BrightEdge LLC, the American Cancer Society's (ACS) venture capital and impact investment arm, is making waves in the fight against cancer. With an active portfolio of 16 companies, it aims to leverage innovation to significantly improve healthcare access. The latest annual report details an impressive total investment of $43 million...

Continue Reading
Constellation Energy's Q3 Earnings Beat Yet Shares Decline

Updated Category News Views 49

Constellation Energy Faces Share Decline Despite Strong Earnings Constellation Energy Corporation (NASDAQ: CEG) recently reported its third-quarter earnings that exceeded analyst predictions, but surprisingly, its shares experienced a notable drop of 7%. This outcome suggests that the market may be reacting to broader concerns rather than the positive financial results...

Continue Reading